Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
Authors
Keywords
-
Journal
Journal of Biological Engineering
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-24
DOI
10.1186/s13036-019-0206-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening
- (2018) Shiyu Dai et al. Viruses-Basel
- Real-time imaging reveals unique heterogeneous population features in insect cell cultures
- (2017) David Hidalgo et al. JOURNAL OF BIOTECHNOLOGY
- Production of virus-like particles for vaccines
- (2017) J. Fuenmayor et al. New Biotechnology
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
- (2017) Sook-Kwan Leang et al. Jove-Journal of Visualized Experiments
- Escherichia coli-derived virus-like particles in vaccine development
- (2017) Xiaofen Huang et al. npj Vaccines
- Progress in developing virus-like particle influenza vaccines
- (2016) Fu-Shi Quan et al. Expert Review of Vaccines
- Engineering virus-like particles as vaccine platforms
- (2016) Kathryn M Frietze et al. Current Opinion in Virology
- Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
- (2015) Christopher Ladd Effio et al. Biotechnology Journal
- Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems
- (2015) Christine M Thompson et al. BMC BIOTECHNOLOGY
- Characterization of Influenza A (H7N9) Viruses Isolated from Human Cases Imported into Taiwan
- (2015) Ji-Rong Yang et al. PLoS One
- Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
- (2015) Ye V. Liu et al. VACCINE
- Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
- (2015) Changgui Li et al. Human Vaccines & Immunotherapeutics
- Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
- (2015) Christopher Ladd Effio et al. Biotechnology Journal
- Evaluation of MDCK Cell-Derived Influenza H7N9 Vaccine Candidates in Ferrets
- (2015) Min-Yuan Chia et al. PLoS One
- Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System
- (2015) Javier López-Vidal et al. PLoS One
- Bioengineering virus-like particles as vaccines
- (2013) Linda H.L. Lua et al. BIOTECHNOLOGY AND BIOENGINEERING
- Virus-like particles for the prevention of human papillomavirus-associated malignancies
- (2013) Joshua W Wang et al. Expert Review of Vaccines
- The first case of H7N9 influenza in Taiwan
- (2013) Sui-Yuan Chang et al. LANCET
- Use of baculovirus expression system for generation of virus-like particles: Successes and challenges
- (2013) Fuxiao Liu et al. PROTEIN EXPRESSION AND PURIFICATION
- Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus
- (2013) Gale E. Smith et al. VACCINE
- Production of Japanese encephalitis virus-like particles in insect cells
- (2013) Hideki Yamaji et al. Bioengineered
- CAP, a new human suspension cell line for influenza virus production
- (2012) Yvonne Genzel et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Scale-up of mouse embryonic stem cell expansion in stirred bioreactors
- (2011) Ana Fernandes-Platzgummer et al. BIOTECHNOLOGY PROGRESS
- Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium
- (2011) Alan Yung-Chih Hu et al. PLoS One
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines
- (2010) Florian Krammer et al. MOLECULAR BIOTECHNOLOGY
- Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus
- (2010) Chia-Ying Wu et al. PLoS One
- Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield
- (2010) Cheng-Yu Chung et al. VACCINE
- Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus
- (2010) Peter Pushko et al. VACCINE
- FluBlok, a recombinant hemagglutinin influenza vaccine
- (2008) Manon M.J. Cox et al. Influenza and Other Respiratory Viruses
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started